Veterinary Antibiotics Market By Animal Type (Cattle, Pigs, Sheep & Goats, Poultry, and Others), By Drug Class (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Trimethoprim, Polymyxins, Aminoglycosides, Fluoroquinolones, and Other), By Dosage Form (Powders, Solutions, Injections, and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Published date: March 2025
Report ID: 141536
Number of Pages: 346
Format:

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    
    2.2.1. Increasing Incidence of Livestock Diseases
    
    2.2.2. Growing Concern over Antimicrobial Resistance (AMR)
    
    2.2.3. Advancements in Precision Medicine
    
    2.2.4. Key Veterinary Antibiotics Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    
    2.9.1. List of Raw Materials Suppliers
    
    2.9.2. List of Veterinary Antibiotics Manufacturers
    
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Veterinary Antibiotics Market Analysis and Forecast, By Segment, 2020-2034
  - 3.1. Key Findings
  - 3.2. Global Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Animal Type, 2020-2034
  - 3.3. Global Veterinary Antibiotics Market Attractiveness Analysis, By Animal Type
    
    3.3.1. Cattle
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
    
    3.3.2. Pigs
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
    
    3.3.3. Sheep & Goats
    
    3.3.3.1. Insights
    
    3.3.3.2. Key Takeaways
    
    3.3.4. Poultry
    
    3.3.4.1. Insights
    
    3.3.4.2. Key Takeaways
    
    3.3.5. Others
    
    3.3.5.1. Insights
    
    3.3.5.2. Key Takeaways
  - 3.4. Global Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  - 3.5. Global Veterinary Antibiotics Market Attractiveness Analysis, By Drug Class
    
    3.5.1. Tetracyclines
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
    
    3.5.2. Penicillins
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
    
    3.5.3. Sulfonamides
    
    3.5.3.1. Insights
    
    3.5.3.2. Key Takeaways
    
    3.5.4. Macrolides
    
    3.5.4.1. Insights
    
    3.5.4.2. Key Takeaways
    
    3.5.5. Trimethoprim
    
    3.5.5.1. Insights
    
    3.5.5.2. Key Takeaways
    
    3.5.6. Polymyxins
    
    3.5.6.1. Insights
    
    3.5.6.2. Key Takeaways
    
    3.5.7. Aminoglycosides
    
    3.5.7.1. Insights
    
    3.5.7.2. Key Takeaways
    
    3.5.8. Fluoroquinolones
    
    3.5.8.1. Insights
    
    3.5.8.2. Key Takeaways
    
    3.5.9. Other
    
    3.5.9.1. Insights
    
    3.5.9.2. Key Takeaways
  - 3.6. Global Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Dosage Form, 2020-2034
  - 3.7. Global Veterinary Antibiotics Market Attractiveness Analysis, By Dosage Form
    
    3.7.1. Powders
    
    3.7.1.1. Insights
    
    3.7.1.2. Key Takeaways
    
    3.7.2. Solutions
    
    3.7.2.1. Insights
    
    3.7.2.2. Key Takeaways
    
    3.7.3. Injections
    
    3.7.3.1. Insights
    
    3.7.3.2. Key Takeaways
    
    3.7.4. Others
    
    3.7.4.1. Insights
    
    3.7.4.2. Key Takeaways
- 4. Global Veterinary Antibiotics Market Analysis and Forecast, By Region, 2020-2034
  - 4.1. Key Findings
  - 4.2. Global Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    
    4.2.1. North America
    
    4.2.1.1. Regional Insights
    
    4.2.2. Europe
    
    4.2.2.1. Regional Insights
    
    4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
    
    4.2.4. Latin America
    
    4.2.4.1. Regional Insights
    
    4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
  - 4.3. Global Veterinary Antibiotics Market Attractiveness Analysis, By Region
- 5. North America Veterinary Antibiotics Market Analysis and Forecast, 2020-2034
  - 5.1. Key Findings
  - 5.2. North America Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Animal Type, 2020-2034
  - 5.3. North America Veterinary Antibiotics Market Attractiveness Analysis, By Animal Type
  - 5.4. North America Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  - 5.5. North America Veterinary Antibiotics Market Attractiveness Analysis, By Drug Class
  - 5.6. North America Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Dosage Form, 2020-2034
  - 5.7. North America Veterinary Antibiotics Market Attractiveness Analysis, By Dosage Form
  - 5.8. North America Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 5.9. North America Veterinary Antibiotics Market Attractiveness Analysis, By Country
    
    5.9.1. The US
    
    5.9.2. Canada
- 6. Europe Veterinary Antibiotics Market Analysis and Forecast, 2020-2034
  - 6.1. Key Findings
  - 6.2. Europe Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Animal Type, 2020-2034
  - 6.3. Europe Veterinary Antibiotics Market Attractiveness Analysis, By Animal Type
  - 6.4. Europe Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  - 6.5. Europe Veterinary Antibiotics Market Attractiveness Analysis, By Drug Class
  - 6.6. Europe Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Dosage Form, 2020-2034
  - 6.7. Europe Veterinary Antibiotics Market Attractiveness Analysis, By Dosage Form
  - 6.8. Europe Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 6.9. Europe Veterinary Antibiotics Market Attractiveness Analysis, By Country
    
    6.9.1. Germany
    
    6.9.2. The UK
    
    6.9.3. France
    
    6.9.4. Spain
    
    6.9.5. Italy
    
    6.9.6. Russia
    
    6.9.7. Netherland
    
    6.9.8. Rest of Europe
- 7. Asia Pacific Veterinary Antibiotics Market Analysis and Forecast, 2020-2034
  - 7.1. Key Findings
  - 7.2. Asia Pacific Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Animal Type, 2020-2034
  - 7.3. Asia Pacific Veterinary Antibiotics Market Attractiveness Analysis, By Animal Type
  - 7.4. Asia Pacific Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  - 7.5. Asia Pacific Veterinary Antibiotics Market Attractiveness Analysis, By Drug Class
  - 7.6. Asia Pacific Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Dosage Form, 2020-2034
  - 7.7. Asia Pacific Veterinary Antibiotics Market Attractiveness Analysis, By Dosage Form
  - 7.8. Asia Pacific Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 7.9. Asia Pacific Veterinary Antibiotics Market Attractiveness Analysis, By Country
    
    7.9.1. China
    
    7.9.2. Japan
    
    7.9.3. South Korea
    
    7.9.4. India
    
    7.9.5. Australia
    
    7.9.6. New Zealand
    
    7.9.7. Singapore
    
    7.9.8. Thailand
    
    7.9.9. Vietnam
    
    7.9.10. Rest of Asia Pacific
- 8. Latin America Veterinary Antibiotics Market Analysis and Forecast, 2020-2034
  - 8.1. Key Findings
  - 8.2. Latin America Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Animal Type, 2020-2034
  - 8.3. Latin America Veterinary Antibiotics Market Attractiveness Analysis, By Animal Type
  - 8.4. Latin America Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  - 8.5. Latin America Veterinary Antibiotics Market Attractiveness Analysis, By Drug Class
  - 8.6. Latin America Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Dosage Form, 2020-2034
  - 8.7. Latin America Veterinary Antibiotics Market Attractiveness Analysis, By Dosage Form
  - 8.8. Latin America Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 8.9. Latin America Veterinary Antibiotics Market Attractiveness Analysis, By Country
    
    8.9.1. Brazil
    
    8.9.2. Mexico
    
    8.9.3. Rest of Latin America
- 9. Middle East & Africa Veterinary Antibiotics Market Analysis and Forecast, 2020-2034
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Animal Type, 2020-2034
  - 9.3. Middle East & Africa Veterinary Antibiotics Market Attractiveness Analysis, By Animal Type
  - 9.4. Middle East & Africa Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  - 9.5. Middle East & Africa Veterinary Antibiotics Market Attractiveness Analysis, By Drug Class
  - 9.6. Middle East & Africa Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Dosage Form, 2020-2034
  - 9.7. Middle East & Africa Veterinary Antibiotics Market Attractiveness Analysis, By Dosage Form
  - 9.8. Middle East & Africa Veterinary Antibiotics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 9.9. Middle East & Africa Veterinary Antibiotics Market Attractiveness Analysis, By Country
    
    9.9.1. South Africa
    
    9.9.2. Saudi Arabia
    
    9.9.3. UAE
    
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    
    10.7.1. Merck & Co., Inc.
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Product Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
    
    10.7.2. Ceva Santé Animale.
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Product Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
    
    10.7.3. Vetoquinol
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Product Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
    
    10.7.4. Zoetis Services LLC
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Product Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
    
    10.7.5. Boehringer Ingelheim International GmbH
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Product Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
    
    10.7.6. Dechra Pharmaceuticals PLC
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Product Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
    
    10.7.7. Elanco Animal Health Incorporated
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Product Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
    
    10.7.8. Virbac S.A.
    
    10.7.8.1. Company Details
    
    10.7.8.2. Business Overview
    
    10.7.8.3. Product Portfolio
    
    10.7.8.4. Financial Insights
    
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.8.6. SWOT Analysis
    
    10.7.8.7. Geographic Footprint
    
    10.7.9. Calier
    
    10.7.9.1. Company Details
    
    10.7.9.2. Business Overview
    
    10.7.9.3. Product Portfolio
    
    10.7.9.4. Financial Insights
    
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.9.6. SWOT Analysis
    
    10.7.9.7. Geographic Footprint
    
    10.7.10. Bimeda, Inc
    
    10.7.10.1. Company Details
    
    10.7.10.2. Business Overview
    
    10.7.10.3. Product Portfolio
    
    10.7.10.4. Financial Insights
    
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.10.6. SWOT Analysis
    
    10.7.10.7. Geographic Footprint
    
    10.7.11. Prodivet pharmaceuticals SA/NV
    
    10.7.11.1. Company Details
    
    10.7.11.2. Business Overview
    
    10.7.11.3. Product Portfolio
    
    10.7.11.4. Financial Insights
    
    10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.11.6. SWOT Analysis
    
    10.7.11.7. Geographic Footprint
    
    10.7.12. Norbrook Laboratories
    
    10.7.12.1. Company Details
    
    10.7.12.2. Business Overview
    
    10.7.12.3. Product Portfolio
    
    10.7.12.4. Financial Insights
    
    10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.12.6. SWOT Analysis
    
    10.7.12.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
- List of Tables
  - Table 1. Global Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 2. Global Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 3. Global Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 4. Global Veterinary Antibiotics Market Value (US$ Mn), By Region, 2020-2034
  - Table 5. North America Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 6. North America Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 7. North America Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 8. North America Veterinary Antibiotics Market Value (US$ Mn), By Country, 2020-2034
  - Table 9. The US Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 10. The US Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 11. The US Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 12. Canada Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 13. Canada Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 14. Canada Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 15. Europe Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 16. Europe Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 17. Europe Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 18. Europe Veterinary Antibiotics Market Value (US$ Mn), By Country, 2020-2034
  - Table 19. Germany Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 20. Germany Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 21. Germany Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 22. The UK Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 23. The UK Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 24. The UK Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 25. France Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 26. France Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 27. France Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 28. Spain Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 29. Spain Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 30. Spain Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 31. Italy Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 32. Italy Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 33. Italy Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 34. Russia Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 35. Russia Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 36. Russia Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 37. Netherland Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 38. Netherland Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 39. Netherland Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 40. Rest of Europe Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 41. Rest of Europe Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 42. Rest of Europe Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 43. Asia Pacific Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 44. Asia Pacific Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 45. Asia Pacific Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 46. Asia Pacific Veterinary Antibiotics Market Value (US$ Mn), By Country, 2020-2034
  - Table 47. China Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 48. China Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 49. China Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 50. India Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 51. India Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 52. India Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 53. Japan Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 54. Japan Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 55. Japan Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 56. South Korea Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 57. South Korea Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 58. South Korea Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 59. Australia Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 60. Australia Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 61. Australia Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 62. New Zealand Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 63. New Zealand Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 64. New Zealand Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 65. Singapore Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 66. Singapore Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 67. Singapore Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 68. Thailand Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 69. Thailand Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 70. Thailand Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 71. Vietnam Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 72. Vietnam Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 73. Vietnam Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 74. Rest of Asia Pacific Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 75. Rest of Asia Pacific Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 76. Rest of Asia Pacific Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 77. Latin America Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 78. Latin America Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 79. Latin America Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 80. Latin America Veterinary Antibiotics Market Value (US$ Mn), By Country, 2020-2034
  - Table 81. Brazil Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 82. Brazil Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 83. Brazil Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 84. Mexico Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 85. Mexico Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 86. Mexico Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 87. Rest of Latin America Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 88. Rest of Latin America Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 89. Rest of Latin America Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 90. Middle East & Africa Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 91. Middle East & Africa Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 92. Middle East & Africa Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 93. Middle East & Africa Veterinary Antibiotics Market Value (US$ Mn), By Country, 2020-2034
  - Table 94. South Africa Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 95. South Africa Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 96. South Africa Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 97. Saudi Arabia Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 98. Saudi Arabia Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 99. Saudi Arabia Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 100. UAE Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 101. UAE Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 102. UAE Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
  - Table 103. Rest of Middle East & Africa Veterinary Antibiotics Market Value (US$ Mn), By Animal Type, 2020-2034
  - Table 104. Rest of Middle East & Africa Veterinary Antibiotics Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 105. Rest of Middle East & Africa Veterinary Antibiotics Market Value (US$ Mn), By Dosage Form, 2020-2034
- List of Figures
  - Figure 1. Global Veterinary Antibiotics Market Snapshot: Market Value (US$ Mn), 2020-2034
  - Figure 2. Opportunity Map
  - Figure 3. Opportunity Orbit
  - Figure 4. Regional Market Share and BPS Analysis in Veterinary Antibiotics Market
  - Figure 5. Global Veterinary Antibiotics Market Analysis, By Animal Type, 2020, 2024 and 2034
  - Figure 6. Global Veterinary Antibiotics Market Attractiveness Analysis, By Animal Type
  - Figure 7. Global Veterinary Antibiotics Market Analysis, By Drug Class, 2020, 2024 and 2034
  - Figure 8. Global Veterinary Antibiotics Market Attractiveness Analysis, By Drug Class
  - Figure 9. Global Veterinary Antibiotics Market Analysis, By Dosage Form, 2020, 2024 and 2034
  - Figure 10. Global Veterinary Antibiotics Market Attractiveness Analysis, By Dosage Form
  - Figure 11. Global Veterinary Antibiotics Market Analysis, By Region, 2020, 2024 and 2034
  - Figure 12. Global Veterinary Antibiotics Market Attractiveness Analysis, By Region
  - Figure 13. North America Veterinary Antibiotics Market Analysis, By Animal Type, 2020, 2024 and 2034
  - Figure 14. North America Veterinary Antibiotics Market Attractiveness Analysis, By Animal Type
  - Figure 15. North America Veterinary Antibiotics Market (US$ Mn), by Cattle, 2020-2034
  - Figure 16. North America Veterinary Antibiotics Market (US$ Mn), by Pigs, 2020-2034
  - Figure 17. North America Veterinary Antibiotics Market (US$ Mn), by Sheep & Goats, 2020-2034
  - Figure 18. North America Veterinary Antibiotics Market (US$ Mn), by Poultry, 2020-2034
  - Figure 19. North America Veterinary Antibiotics Market (US$ Mn), by Others, 2020-2034
  - Figure 20. North America Veterinary Antibiotics Market Analysis, By Drug Class, 2020, 2024 and 2034
  - Figure 21. North America Veterinary Antibiotics Market Attractiveness Analysis, By Drug Class
  - Figure 22. North America Veterinary Antibiotics Market (US$ Mn), by Tetracyclines, 2020-2034
  - Figure 23. North America Veterinary Antibiotics Market (US$ Mn), by Penicillins, 2020-2034
  - Figure 24. North America Veterinary Antibiotics Market (US$ Mn), by Sulfonamides, 2020-2034
  - Figure 25. North America Veterinary Antibiotics Market (US$ Mn), by Macrolides, 2020-2034
  - Figure 26. North America Veterinary Antibiotics Market (US$ Mn), by Trimethoprim, 2020-2034
  - Figure 27. North America Veterinary Antibiotics Market (US$ Mn), by Polymyxins, 2020-2034
  - Figure 28. North America Veterinary Antibiotics Market (US$ Mn), by Aminoglycosides, 2020-2034
  - Figure 29. North America Veterinary Antibiotics Market (US$ Mn), by Fluoroquinolones, 2020-2034
  - Figure 30. North America Veterinary Antibiotics Market (US$ Mn), by Other, 2020-2034
  - Figure 31. North America Veterinary Antibiotics Market Analysis, By Dosage Form, 2020, 2024 and 2034
  - Figure 32. North America Veterinary Antibiotics Market Attractiveness Analysis, By Dosage Form
  - Figure 33. North America Veterinary Antibiotics Market (US$ Mn), by Powders, 2020-2034
  - Figure 34. North America Veterinary Antibiotics Market (US$ Mn), by Solutions, 2020-2034
  - Figure 35. North America Veterinary Antibiotics Market (US$ Mn), by Injections, 2020-2034
  - Figure 36. North America Veterinary Antibiotics Market (US$ Mn), by Others, 2020-2034
  - Figure 37. North America Veterinary Antibiotics Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 38. North America Veterinary Antibiotics Market Attractiveness Analysis, By Country
  - Figure 39. Europe Veterinary Antibiotics Market Analysis, By Animal Type, 2020, 2024 and 2034
  - Figure 40. Europe Veterinary Antibiotics Market Attractiveness Analysis, By Animal Type
  - Figure 41. Europe Veterinary Antibiotics Market (US$ Mn), by Cattle, 2020-2034
  - Figure 42. Europe Veterinary Antibiotics Market (US$ Mn), by Pigs, 2020-2034
  - Figure 43. Europe Veterinary Antibiotics Market (US$ Mn), by Sheep & Goats, 2020-2034
  - Figure 44. Europe Veterinary Antibiotics Market (US$ Mn), by Poultry, 2020-2034
  - Figure 45. Europe Veterinary Antibiotics Market (US$ Mn), by Others, 2020-2034
  - Figure 46. Europe Veterinary Antibiotics Market Analysis, By Drug Class, 2020, 2024 and 2034
  - Figure 47. Europe Veterinary Antibiotics Market Attractiveness Analysis, By Drug Class
  - Figure 48. Europe Veterinary Antibiotics Market (US$ Mn), by Tetracyclines, 2020-2034
  - Figure 49. Europe Veterinary Antibiotics Market (US$ Mn), by Penicillins, 2020-2034
  - Figure 50. Europe Veterinary Antibiotics Market (US$ Mn), by Sulfonamides, 2020-2034
  - Figure 51. Europe Veterinary Antibiotics Market (US$ Mn), by Macrolides, 2020-2034
  - Figure 52. Europe Veterinary Antibiotics Market (US$ Mn), by Trimethoprim, 2020-2034
  - Figure 53. Europe Veterinary Antibiotics Market (US$ Mn), by Polymyxins, 2020-2034
  - Figure 54. Europe Veterinary Antibiotics Market (US$ Mn), by Aminoglycosides, 2020-2034
  - Figure 55. Europe Veterinary Antibiotics Market (US$ Mn), by Fluoroquinolones, 2020-2034
  - Figure 56. Europe Veterinary Antibiotics Market (US$ Mn), by Other, 2020-2034
  - Figure 57. Europe Veterinary Antibiotics Market Analysis, By Dosage Form, 2020, 2024 and 2034
  - Figure 58. Europe Veterinary Antibiotics Market Attractiveness Analysis, By Dosage Form
  - Figure 59. Europe Veterinary Antibiotics Market (US$ Mn), by Powders, 2020-2034
  - Figure 60. Europe Veterinary Antibiotics Market (US$ Mn), by Solutions, 2020-2034
  - Figure 61. Europe Veterinary Antibiotics Market (US$ Mn), by Injections, 2020-2034
  - Figure 62. Europe Veterinary Antibiotics Market (US$ Mn), by Others, 2020-2034
  - Figure 63. Europe Veterinary Antibiotics Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 64. Europe Veterinary Antibiotics Market Attractiveness Analysis, By Country
  - Figure 65. Asia Pacific Veterinary Antibiotics Market Analysis, By Animal Type, 2020, 2024 and 2034
  - Figure 66. Asia Pacific Veterinary Antibiotics Market Attractiveness Analysis, By Animal Type
  - Figure 67. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Cattle, 2020-2034
  - Figure 68. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Pigs, 2020-2034
  - Figure 69. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Sheep & Goats, 2020-2034
  - Figure 70. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Poultry, 2020-2034
  - Figure 71. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Others, 2020-2034
  - Figure 72. Asia Pacific Veterinary Antibiotics Market Analysis, By Drug Class, 2020, 2024 and 2034
  - Figure 73. Asia Pacific Veterinary Antibiotics Market Attractiveness Analysis, By Drug Class
  - Figure 74. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Tetracyclines, 2020-2034
  - Figure 75. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Penicillins, 2020-2034
  - Figure 76. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Sulfonamides, 2020-2034
  - Figure 77. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Macrolides, 2020-2034
  - Figure 78. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Trimethoprim, 2020-2034
  - Figure 79. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Polymyxins, 2020-2034
  - Figure 80. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Aminoglycosides, 2020-2034
  - Figure 81. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Fluoroquinolones, 2020-2034
  - Figure 82. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Other, 2020-2034
  - Figure 83. Asia Pacific Veterinary Antibiotics Market Analysis, By Dosage Form, 2020, 2024 and 2034
  - Figure 84. Asia Pacific Veterinary Antibiotics Market Attractiveness Analysis, By Dosage Form
  - Figure 85. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Powders, 2020-2034
  - Figure 86. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Solutions, 2020-2034
  - Figure 87. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Injections, 2020-2034
  - Figure 88. Asia Pacific Veterinary Antibiotics Market (US$ Mn), by Others, 2020-2034
  - Figure 89. Asia Pacific Veterinary Antibiotics Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 90. Asia Pacific Veterinary Antibiotics Market Attractiveness Analysis, By Country
  - Figure 91. Latin America Veterinary Antibiotics Market Analysis, By Animal Type, 2020, 2024 and 2034
  - Figure 92. Latin America Veterinary Antibiotics Market Attractiveness Analysis, By Animal Type
  - Figure 93. Latin America Veterinary Antibiotics Market (US$ Mn), by Cattle, 2020-2034
  - Figure 94. Latin America Veterinary Antibiotics Market (US$ Mn), by Pigs, 2020-2034
  - Figure 95. Latin America Veterinary Antibiotics Market (US$ Mn), by Sheep & Goats, 2020-2034
  - Figure 96. Latin America Veterinary Antibiotics Market (US$ Mn), by Poultry, 2020-2034
  - Figure 97. Latin America Veterinary Antibiotics Market (US$ Mn), by Others, 2020-2034
  - Figure 98. Latin America Veterinary Antibiotics Market Analysis, By Drug Class, 2020, 2024 and 2034
  - Figure 99. Latin America Veterinary Antibiotics Market Attractiveness Analysis, By Drug Class
  - Figure 100. Latin America Veterinary Antibiotics Market (US$ Mn), by Tetracyclines, 2020-2034
  - Figure 101. Latin America Veterinary Antibiotics Market (US$ Mn), by Penicillins, 2020-2034
  - Figure 102. Latin America Veterinary Antibiotics Market (US$ Mn), by Sulfonamides, 2020-2034
  - Figure 103. Latin America Veterinary Antibiotics Market (US$ Mn), by Macrolides, 2020-2034
  - Figure 104. Latin America Veterinary Antibiotics Market (US$ Mn), by Trimethoprim, 2020-2034
  - Figure 105. Latin America Veterinary Antibiotics Market (US$ Mn), by Polymyxins, 2020-2034
  - Figure 106. Latin America Veterinary Antibiotics Market (US$ Mn), by Aminoglycosides, 2020-2034
  - Figure 107. Latin America Veterinary Antibiotics Market (US$ Mn), by Fluoroquinolones, 2020-2034
  - Figure 108. Latin America Veterinary Antibiotics Market (US$ Mn), by Other, 2020-2034
  - Figure 109. Latin America Veterinary Antibiotics Market Analysis, By Dosage Form, 2020, 2024 and 2034
  - Figure 110. Latin America Veterinary Antibiotics Market Attractiveness Analysis, By Dosage Form
  - Figure 111. Latin America Veterinary Antibiotics Market (US$ Mn), by Powders, 2020-2034
  - Figure 112. Latin America Veterinary Antibiotics Market (US$ Mn), by Solutions, 2020-2034
  - Figure 113. Latin America Veterinary Antibiotics Market (US$ Mn), by Injections, 2020-2034
  - Figure 114. Latin America Veterinary Antibiotics Market (US$ Mn), by Others, 2020-2034
  - Figure 115. Latin America Veterinary Antibiotics Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 116. Latin America Veterinary Antibiotics Market Attractiveness Analysis, By Country
  - Figure 117. Middle East & Africa Veterinary Antibiotics Market Analysis, By Animal Type, 2020, 2024 and 2034
  - Figure 118. Middle East & Africa Veterinary Antibiotics Market Attractiveness Analysis, By Animal Type
  - Figure 119. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Cattle, 2020-2034
  - Figure 120. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Pigs, 2020-2034
  - Figure 121. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Sheep & Goats, 2020-2034
  - Figure 122. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Poultry, 2020-2034
  - Figure 123. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Others, 2020-2034
  - Figure 124. Middle East & Africa Veterinary Antibiotics Market Analysis, By Drug Class, 2020, 2024 and 2034
  - Figure 125. Middle East & Africa Veterinary Antibiotics Market Attractiveness Analysis, By Drug Class
  - Figure 126. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Tetracyclines, 2020-2034
  - Figure 127. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Penicillins, 2020-2034
  - Figure 128. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Sulfonamides, 2020-2034
  - Figure 129. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Macrolides, 2020-2034
  - Figure 130. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Trimethoprim, 2020-2034
  - Figure 131. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Polymyxins, 2020-2034
  - Figure 132. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Aminoglycosides, 2020-2034
  - Figure 133. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Fluoroquinolones, 2020-2034
  - Figure 134. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Other, 2020-2034
  - Figure 135. Middle East & Africa Veterinary Antibiotics Market Analysis, By Dosage Form, 2020, 2024 and 2034
  - Figure 136. Middle East & Africa Veterinary Antibiotics Market Attractiveness Analysis, By Dosage Form
  - Figure 137. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Powders, 2020-2034
  - Figure 138. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Solutions, 2020-2034
  - Figure 139. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Injections, 2020-2034
  - Figure 140. Middle East & Africa Veterinary Antibiotics Market (US$ Mn), by Others, 2020-2034
  - Figure 141. Middle East & Africa Veterinary Antibiotics Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 142. Middle East & Africa Veterinary Antibiotics Market Attractiveness Analysis, By Country
- Merck & Co. Inc.
- Ceva Santé Animale.
- Vetoquinol
- Zoetis Services LLC
- Boehringer Ingelheim International GmbH
- Dechra Pharmaceuticals PLC
- Elanco Animal Health Incorporated
- Virbac S.A.
- Calier
- Bimeda Inc
- Prodivet pharmaceuticals SA/NV
- Norbrook Laboratories
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 141536
Published Date March 2025
Rating
- ★★★★★
  
  ★★★★★
- (142)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)